Current research shows that EGFR is highly expressed in a variety of epithelial tumors, especially in liver cancer, colorectal cancer, breast cancer and so on, and its expression level is closely related to tumor metastasis and prognosis [31, 32]. Here, EGFR is linked to breast cancer.